Lobular neoplasia: Core needle breast biopsy underestimation of malignancy in relation to radiologic and pathologic features

Breast

Volumn 17, Issue 6, 2008, Pages 623-630

  Londero, Viviana ^a   Zuiani, Chiara ^a   Linda, Anna ^a   Vianello, Elena ^a   Furlan, Alessandro ^a   Bazzocchi, Massimo ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

Atypical lobular hyperplasia (ALH); Breast neoplasm; Breast proliferative high risk lesions; Core needle breast biopsy; Lobular carcinoma in situ (LCIS); Lobular neoplasia

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; BREAST HYPERPLASIA; CARCINOMA IN SITU; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECHOMAMMOGRAPHY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MASTECTOMY; NEEDLE BIOPSY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEREOTACTIC BIOPSY; TUMOR CLASSIFICATION; TUMOR VOLUME;

EID: 56649112932     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2008.05.007     Document Type: Article

References (57)

1. Parker S.H., Jobe W.E., Dennis M.A., Stavros A.T., Johnson K.K., Yakes W.F., et al. US-guided automated large-core breast biopsy. Radiology 187 (1993) 507-511
2. Parker S.H., Lovin J.D., Jobe W.E., Burke B.J., Hopper K.I., and Yakes W.F. Nonpalpable breast lesions: stereotactic automated large-core biopsies. Radiology 180 (1991) 403-407
3. Parker S.H., Burbank F., Jackman R.J., Ancreman C.J., Cardenosa G., Cink T.M., et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 193 (1994) 359-364
4. Bazzocchi M., Zuiani C., Bendini M., Dalpiaz G., Anania G., and Di Loreto C. US-guided breast biopsy with an automated cutting needle. Eur Radiol 4 (1994) 360-363
5. Gisvold J.J., Goellner J.R., Grant C.S., Donohue J.H., Sykes M.W., Karsell P.R., et al. Breast biopsy: a comparative study of stereotaxically guided core and excisional techniques. Am J Roentgenol 162 (1994) 815-820
6. Elvecrog E.L., Lechner M.C., and Nelson M.T. Non-palpable breast lesions: correlation of stereotactic large-core needle biopsy and surgical biopsy results. Radiology 188 (1993) 453-455
7. Liberman L., Dershaw D.D., Glassman J.R., Abramson A.F., Morris E.A., LaTrenta L.R., et al. Analysis of cancers not diagnosed at stereotactic core breast biopsy. Radiology 203 (1997) 151-157
8. Liberman L. Clinical management issues in percutaneous core breast biopsy. Radiol Clin North Am 38 4 (2000 Jul) 791-807
9. Liberman L. Percutaneous image-guided core breast biopsy. Radiol Clin North Am 40 3 (2002 May) 483-500
10. Berg W.A. Image-guided breast biopsy and management of high-risk lesions. Radiol Clin North Am 42 5 (2004 Sep) 935-946 vii
11. Jacobs T.W., Connolly J.L., and Schnitt S.J. Nonmalignant lesions in breast core needle biopsies: to excise or not to excise?. Am J Surg Pathol 26 9 (2002 Sep) 1095-1110
12. Simmons R.M., and Osborne M.P. The evaluation of high risk and pre-invasive breast lesions and the decision process for follow up and surgical intervention. Surg Oncol 8 2 (1999 Aug) 55-65
13. Philpotts L.E., Shaheen N.A., Jain K.S., Carter D., and Lee C.H. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology 216 3 (2000 Sep) 831-837
14. Reynolds H.E. Core needle biopsy of challenging benign breast conditions: a comprehensive literature review. Am J Roentgenol 174 5 (2000 May) 1245-1250
15. Houssami N., Ciatto S., Bilous M., Vezzosi V., and Bianchi S. Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3). Br J Cancer 96 (2007) 1253-1257
16. Houssami N., Ciatto S., Ellis I., and Ambrogetti D. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer 109 3 (2007 Feb 1) 487-495
17. Esserman L.E., Lamea L., Tanev S., and Poppiti R. Should the extent of lobular neoplasia on core biopsy influence the decision for excision?. Breast J 13 (2007) 55-61
18. Page D.L., Kidd T.E., Dupont W.D., Simpson J.F., and Rogers L.W. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22 (1991) 1232-1239
19. O'Driscoll D., Britton P., Bobrow L., Wishart G.C., Sinnatamby R., and Warren R. Lobular carcinoma in situ on core biopsy. What is the clinical significance?. Clin Radiol 56 (2001) 216-220
20. Shin S.J., and Rosen P.P. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med 126 (2002) 697-701
21. Bauer V.P., Ditkoff B.A., Schnabel F., Brenin D., El-Tamer M., and Smith S. The management of lobular neoplasia identified on percutaneous core breast biopsy. Breast J 9 (2003) 4-9
22. Dmytrasz K., Tartter P.I., Mizrachy H., Chinitz L., Rosenbaum Smith S., and Estabrook A. The significance of atypical lobular hyperplasia at percutaneous breast biopsy. Breast J 9 (2003) 10-12
23. Foster M.C., Helvie M.A., Gregory N.E., Rebner M., Nees A.V., and Paramagul C. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?. Radiology 231 (2004) 813-819
24. Arpino G., Allred D.C., Mohsin S.K., Wiess H.L., Conrow D., and Elledge R.M. Lobular neoplasia on core-needle biopsy - clinical significance. Cancer 101 (2004) 242-250
25. Middleton L.P., Grant S., Stephens T., Stelling C.B., Sneige N., and Sahin A.A. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?. Mod Pathol 16 (2003) 120-129
26. Cohen M.A. Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why. Radiology 231 (2004) 617-621
27. Frykberg E.R. Lobular carcinoma in situ of the breast. Breast J 5 (1999) 296-338
28. Liberman L., Sama M., Susnik B., Rosen P.P., LaTrenta L.R., Morris E.A., et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. Am J Roentgenol 173 2 (1999 Aug) 291-299
29. Renshaw A.A., Cartagena N., Derhagopian R.P., and Gould E.W. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol 117 (2002) 797-799
30. Zuiani C., Bazzocchi M., Dalpiaz G., Anania G., and Di Loreto C. Dispositivi automatici nella biopsia istologica della mammella. Radiol Med 90 (1995) 846-848
31. Zuiani C., Londero V., Bestagno A., Puglisi F., Di Loreto C., and Bazzocchi M. Proliferative high-risk lesions of the breast: contribution and limits of US-guided core biopsy. Radiol Med 110 (2005) 589-602
32. American College of Radiology (ACR). Breast Imaging Reporting and Data System (BI-RADS) atlas (2003), American College of Radiology, Reston, VA
33. Houssami N., and Irwig L. Likelihood ratios for clinical examination, mammography, ultrasound and fine needle biopsy in women with breast problems. Breast 7 (1998) 85-89
34. Foote Jr. F.W., and Stewart F.W. Lobular carcinoma in situ: a rare form of mammary carcinoma. Am J Pathol 17 (1941) 491
35. Morrow M., and Schnitt S.J. Lobular carcinoma in situ. Chapter 11. In: Harris J.R., Lipman M.E., Morrow M., and Osborne C.K. (Eds). Disease of the breast. 3rd ed (2004), Lipincott Williams and Wilkins, Boston, MA 369-372
36. Arpino G., Laucirica R., and Elledge R.M. Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 143 6 (2005 Sep 20) 446-457
37. Jacobs T.W., Pliss N., Kouria G., and Schnitt S.J. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol 25 2 (2001 Feb) 229-236
38. Goldstein N.S., Kestin L.L., and Vicini F.A. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast. Cancer 92 (2001) 738-747
39. Sewell C.W. Pathology of high-risk breast lesions and ductal carcinoma in situ. Radiol Clin North Am 42 5 (2004 Sep) 821-830 v
40. Sapino A., Frigerio A., Peterse J.L., Arisio R., Coluccia C., and Bussolati G. Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch 436 5 (2000 May) 421-430
41. Georgian-Smith D., and Lawton T.J. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. Am J Roentgenol 176 5 (2001 May) 1255-1259
42. Elsheikh T.M., and Silverman J.F. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol 29 4 (2005 Apr) 534-543
43. Mahoney M.C., Robinson-Smith T.M., and Shaughnessy E.A. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. Am J Roentgenol 187 4 (2006 Oct) 949-954
44. Stein L.F., Zisman G., Rapelyea J.A., Schwartz A.M., Abell B., and Brem R.F. Lobular carcinoma in situ of the breast presenting as a mass. Am J Roentgenol 184 6 (2005 Jun) 1799-1801
45. NHS Cancer Screening Programmes. Royal College of Pathologists. Guidelines for non operative diagnostic procedures and reporting in breast cancer screening. Publication No. 50 (2001), NHSBSP, Sheffield, UK
46. Rosen P.P., Braun Jr. D.W., and Kinne D.E. The clinical significance of pre-invasive breast carcinoma. Cancer 46 Suppl. 4 (1980 Aug 15) 919-925
47. Bodian C.A., Perzin K.H., and Lattes R. Lobular neoplasia: long term risk of breast cancer and relation to other factors. Cancer 78 5 (1996 Sep 1) 1024-1034
48. Osborne M.P., and Hoda S.A. Current management of lobular carcinoma in situ of the breast. Oncology (Williston Park) 8 2 (1994 Feb) 45-49
49. Page D.L., Schuyler P.A., Dupont W.D., Jensen R.A., Plummer Jr. W.D., and Simpson J.F. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361 9352 (2003 Jan 11) 125-129
50. Li C.I., Malone K.E., Saltzman B.S., and Daling J.R. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Cancer 106 10 (2006 May 15) 2104-2112
51. Lakhani S.R., Audretsch W., Cleton-Jensen A.M., Cutuli B., Ellis I., Eusebi V., et al. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?. Eur J Cancer 42 (2006) 2205-2211
52. Cutuli B., de Lafontan B., Quetin P., and Mery E. Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ?. Eur J Cancer 41 3 (2005) 380-385
53. Dershaw D.D. Does LCIS or ALH without other high-risk lesions diagnosed on core biopsy require surgical excision?. Breast J 9 1 (2003 Jan-Feb) 1-3
54. Lee A.H.S., Daneley H.E., Pinder S.E., Ellis I.O., Elston C.W., Vujovic P., et al. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3). Histopathology 42 (2003) 331-336
55. Europe against cancer. In: Perry N., Broeders M., de Wolf C., Tornberg S., Holland R., von Karsa L., et al. (Eds). European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed (2006), European Commision, Luxembourg
56. Berg W.A., Mrose H.E., and Ioffe O.B. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology 218 (2001) 503-509
57. Margenthaler J.A., Duke D., Monsees B.S., Barton P.T., Clark C., and Dietz J.R. Correlation between core biopsy and excisional biopsy in breast high-risk lesions. Am J Surg 192 4 (2006 Oct) 534-537